SUBSCRIBE
SUBSCRIBE
News   Drug Development

CytRx Corporation Says Preliminary Results of Cancer Drug Shows Promise

December 8, 2009 | 
1 min read
Bookmark and Share

Reuters -- CytRx Corp said preliminary results from a mid-stage trial of its drug tamibarotene showed promise in the treatment of acute promyelocytic leukemia (APL) in patients failing other treatments.
Clinical research Phase II
MORE ON THIS TOPIC
World Management Team in office silhouette 3d rendering
Drug Development
The Gap Between the Administration’s Pro-Innovation Words and Policy
July 14, 2025
 · 
6 min read
 · 
Lori Ellis
3d rendering medical heart in yellow background
Cardiovascular disease
AstraZeneca’s Baxdrostat Pushes Blood Pressure Lower in Phase III Trial
July 14, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Pictured: Takeda sign at its office in Massachusetts
Neuroscience
Takeda Establishes Lead in Narcolepsy Race With Back-to-Back Phase III Wins
July 14, 2025
 · 
2 min read
 · 
Tristan Manalac
vector illustration arrows miss the target board, concept of lost in focus, failure, fail, mistake
Depression
After Three Strikes, Relmada Abandons Depression Drug Esmethadone 
July 14, 2025
 · 
2 min read
 · 
Tristan Manalac